To read this content please select one of the options below:

Application of options to the pharmaceutical markets: The solutions of corruption and counterfeit drugs in emerging markets

Shin‐Yun Wang (Department of Finance, National Dong Hwa University, Shoufeng, Taiwan)
Chih‐Chiang Hwang (Department of Finance, National Dong Hwa University, Shoufeng, Taiwan and Department of Healthcare Administration, Tajen University, Pingtung, Taiwan)

International Journal of Accounting & Information Management

ISSN: 1834-7649

Article publication date: 7 June 2011

1044

Abstract

Purpose

The purpose of this paper is to apply options to the pharmaceutical markets to solute the corruption and counterfeit drugs in emerging markets.

Design/methodology/approach

This article proposes a framework for using pharmaceutical options. The application of options to pharmaceuticals will enable a freer and more competitive pharmaceutical market, and assist medicine producers and hospitals using pharmaceutical options market to hedge price risk.

Findings

The paper finds that it is possible, for example, to apply the theoretical framework to case studies in pharmaceutical markets.

Research limitations/implications

The present study provides a starting‐point for further research in the pharmaceutical markets sector. The environment of the existing pharmaceutical markets, the implementation of pharmaceutical options, and the potential benefit of such implementation are discussed in details.

Originality/value

This framework has proven to be useful in improving the pharmaceutical markets of the medical industry.

Keywords

Citation

Wang, S. and Hwang, C. (2011), "Application of options to the pharmaceutical markets: The solutions of corruption and counterfeit drugs in emerging markets", International Journal of Accounting & Information Management, Vol. 19 No. 2, pp. 169-181. https://doi.org/10.1108/18347641111136454

Publisher

:

Emerald Group Publishing Limited

Copyright © 2011, Emerald Group Publishing Limited

Related articles